Insider · CIK 0001423029
Christopher Richard Anzalone
ceoofficerdirector
Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). First filing Dec 20, 2024, latest Jan 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $33M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARWR: ARROWHEAD PHARMACEUTICALS, INC.
ARWROct 9, 2026 · close 62.75
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | ARROWHEAD PHARMACEUTICALS, INC. | $872k 13,187 shares | -0% | +579% from low-4% from high | |
| 30Weak | ARROWHEAD PHARMACEUTICALS, INC. | $3.6M 51,726 shares | -1% | +597% from low-2% from high | |
| 45Moderate | ARROWHEAD PHARMACEUTICALS, INC. | $1.8M 26,031 shares | -1% | +582% from low-4% from high | |
| 65Notable | ARROWHEAD PHARMACEUTICALS, INC. | $5.4M 85,000 shares | -2% | +549% from low-9% from high | |
| 65Notable | ARROWHEAD PHARMACEUTICALS, INC. | $12M 184,298 shares | -4% | +585% from low-3% from high | |
| 50Moderate | ARWRsell ARROWHEAD PHARMACEUTICALS, INC. | $1.5M 141,122 shares | -3% | +18% from low-55% from high | |
| 47Moderate | ARWRsell ARROWHEAD PHARMACEUTICALS, INC. | $775k 51,425 shares | -1% | +0% from low-43% from high | |
| 15Weak | ARROWHEAD PHARMACEUTICALS, INC. | $5.3M 300,000 shares | -7% | +0% from low-33% from high | |
| 32Weak | ARROWHEAD PHARMACEUTICALS, INC. | $219k 11,520 shares | -0% | +11% from low-25% from high | |
| 33Weak | ARROWHEAD PHARMACEUTICALS, INC. | $246k 12,563 shares | -0% | +12% from low-25% from high | |
| 39Weak | ARROWHEAD PHARMACEUTICALS, INC. | $567k 26,712 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7,416 | $65.88 | $489k | 3,798,510 | Jan 5, 2026 |
| Jan 2, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,771 | $66.39 | $383k | 3,792,739 | Jan 5, 2026 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +35,181 | $6.15 | $216k | 3,841,107 | Dec 30, 2025 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +16,545 | $6.15 | $102k | 3,857,652 | Dec 30, 2025 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -35,181 | $69.33 | $2.4M | 3,822,471 | Dec 30, 2025 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -16,545 | $68.69 | $1.1M | 3,805,926 | Dec 30, 2025 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy Common Stock)derivative10b5-1 | -35,181 | $0.00 | $0 | 16,545 | Dec 30, 2025 |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy Common Stock)derivative10b5-1 | -16,545 | $0.00 | $0 | 0 | Dec 30, 2025 |
| Dec 19, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,979 | $66.67 | $265k | 3,827,978 | Dec 23, 2025 |
| Dec 19, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8,147 | $68.01 | $554k | 3,819,831 | Dec 23, 2025 |
| Dec 19, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,319 | $68.48 | $90k | 3,818,512 | Dec 23, 2025 |
| Dec 22, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -10,012 | $68.33 | $684k | 3,808,500 | Dec 23, 2025 |
| Dec 22, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,574 | $68.85 | $177k | 3,805,926 | Dec 23, 2025 |
| Dec 17, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -46,287 | $63.55 | $2.9M | 3,870,670 | Dec 19, 2025 |
| Dec 17, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -35,750 | $64.51 | $2.3M | 3,834,920 | Dec 19, 2025 |
| Dec 17, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -982 | $65.53 | $64k | 3,833,938 | Dec 19, 2025 |
| Dec 17, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,981 | $66.30 | $131k | 3,831,957 | Dec 19, 2025 |
| Dec 12, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +180,000 | $0.00 | $0 | 4,101,255 | Dec 16, 2025 |
| Dec 15, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -100,532 | $68.67 | $6.9M | 4,000,723 | Dec 16, 2025 |
| Dec 15, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -21,321 | $69.28 | $1.5M | 3,979,402 | Dec 16, 2025 |
| Dec 15, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -8,147 | $69.96 | $570k | 3,971,255 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -8,416 | $60.51 | $509k | 3,962,839 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -10,963 | $61.25 | $671k | 3,951,876 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -14,095 | $62.12 | $876k | 3,937,781 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -8,476 | $62.94 | $533k | 3,929,305 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -6,661 | $64.29 | $428k | 3,922,644 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,000 | $64.96 | $65k | 3,921,644 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,300 | $65.77 | $86k | 3,920,344 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -166 | $66.77 | $11k | 3,920,178 | Dec 16, 2025 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,221 | $67.87 | $219k | 3,916,957 | Dec 16, 2025 |
| Apr 9, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -35,305 | $9.93 | $351k | 4,027,072 | Apr 11, 2025 |
| Apr 9, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,400 | $10.75 | $37k | 4,023,672 | Apr 11, 2025 |
| Apr 9, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,617 | $11.76 | $19k | 4,022,055 | Apr 11, 2025 |
| Apr 10, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -50,000 | $10.87 | $544k | 3,972,055 | Apr 11, 2025 |
| Apr 11, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -50,800 | $11.49 | $584k | 3,921,255 | Apr 11, 2025 |
| Mar 13, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +340,000 | $0.00 | $0 | 4,113,802 | Mar 17, 2025 |
| Mar 13, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -51,425 | $15.07 | $775k | 4,062,377 | Mar 17, 2025 |
| Mar 3, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +166,667 | $7.75 | $1.3M | 3,940,469 | Mar 5, 2025 |
| Mar 4, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +133,333 | $7.75 | $1.0M | 4,073,802 | Mar 5, 2025 |
| Mar 3, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -166,667 | $18.03 | $3.0M | 3,907,135 | Mar 5, 2025 |
| Mar 4, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -133,333 | $17.02 | $2.3M | 3,773,802 | Mar 5, 2025 |
| Mar 3, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy Common Stock)derivative10b5-1 | -166,667 | $0.00 | $0 | 185,059 | Mar 5, 2025 |
| Mar 3, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy Common Stock)derivative10b5-1 | -133,333 | $0.00 | $0 | 51,726 | Mar 5, 2025 |
| Feb 7, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +9,550 | $20.10 | $192k | 3,773,802 | Feb 10, 2025 |
| Jan 2, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -11,520 | $19.05 | $219k | 3,764,252 | Jan 6, 2025 |
| Dec 23, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -12,563 | $19.59 | $246k | 3,775,772 | Dec 23, 2024 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -12,653 | $20.52 | $260k | 3,702,394 | Dec 20, 2024 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8,260 | $21.74 | $180k | 3,694,134 | Dec 20, 2024 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,799 | $22.12 | $128k | 3,688,335 | Dec 20, 2024 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +100,000 | $0.00 | $0 | 3,788,335 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.